Ontario women to get PET scans to help plan treatment in locally advanced cervix cancer

September 14, 2018, University Health Network

An Ontario clinical study that shows adding PET imaging to conventional CT imaging to stage locally advanced cervix cancer can change treatment means newly diagnosed women in this province may also receive PET imaging.

The findings are published online today by JAMA Network Open. Co-principal investigators Dr. Anthony Fyles, radiation oncologist at Princess Margaret Cancer Centre, and Dr. Lorraine Elit, gynecologic oncologist at Hamilton Health Sciences' Juravinski Cancer Centre, explain:

"We met our goal of determining whether adding PET detects more extensive disease and influences treatment. The study showed that patients who had PET were twice as likely to have a change in their treatment."

Locally advanced cervix cancer—about 40-50 per cent of all cervix cancers—is inoperable, but potentially curable with chemotherapy and radiation therapy. Women eligible for PET have involved or suspicious on CT, in which case PET can show additional nodal disease not seen on CT.

Dr. Fyles, also Professor, Radiation Oncology, University of Toronto, says: "With PET we always learn more about disease, but does that knowledge change what we do in treating patients? In this instance it did and it's extremely gratifying to provide new evidence that changes clinical practice."

Dr. Anthony Fyles, radiation oncologist at Princess Margaret Cancer Centre, discusses the findings of a study published today in JAMA Network Open. Credit: UHN

Dr. Elit, Professor of Obstetrics and Gynecology, McMaster University, Hamilton, says: "This trial was a team effort. It is an example of how physicians who treat with cervical cancer can work together to carry out a high-quality study, the results of which ultimately change practice in our province. As a result of our research, the access to PET scans for women with this disease has expanded in Ontario."

Study author Dr. Mark Levine, Professor of Oncology, and Director, Ontario Clinical Oncology Group (OCOG) at McMaster, adds that although previous studies showed PET could detect more tumour than usual tests, the Ontario randomized trial is the first to evaluate whether PET leads to a change in clinical management.

From 2010-2014, the study, co-ordinated by OCOG and funded by Cancer Care Ontario, enrolled 171 women at six regional cancer centres—the Princess Margaret, Odette Sunnybrook, Juravinski, London, Ottawa and Thunder Bay.

Study participants were over 18 and newly diagnosed. Half the women received a CT, which shows abnormalities or disease in the body area scanned. The other half received a CT plus a PET scan, which reveals "hot spots" of cell activity or growth that can indicate . About twice as many women in the PET arm received more extensive radiation.

Explore further: Prostate cancer trial shows treating with precision radiotherapy cuts course of treatment by 50 percent

Related Stories

Prostate cancer trial shows treating with precision radiotherapy cuts course of treatment by 50 percent

March 16, 2017
An Ontario-led international clinical trial with 1,206 men with localized prostate cancer shows that compressing radiation treatments into four weeks from eight delivers similar outcomes.

Additional radiation reduces breast-cancer recurrence for some patients

July 22, 2015
A study has found no increase in overall survival but a reduction in breast cancer recurrence when additional radiation is given to the lymph nodes as well as the standard treatment of whole-breast irradiation after breast-conserving ...

Breast cancer surgery patients benefit from adding radiation therapy

June 4, 2011
Additional radiation treatment improves disease free survival lessening the chance of cancer recurring in women with early breast cancer who have had breast conserving surgery (lumpectomy), interim results of a new study ...

Most women with early-stage breast cancer undergo imaging for metastatic cancer despite guidelines

June 22, 2015
Most women—about 86%—with early-stage breast cancer will undergo imaging to determine if the cancer has metastasized, despite international guidelines that recommend against testing, found a study in CMAJ (Canadian Medical ...

Radiation plus hormone therapy greatly improves survival

November 3, 2011
Men with locally advanced or high-risk prostate cancer who receive combined radiation and hormone therapy live longer and are less likely to die from their disease, shows clinical research led by radiation oncologists at ...

First patient receives experimental immunotherapy for cancer

May 2, 2017
A Hamilton patient is the first trial participant to receive a novel experimental immunotherapy treatment for lung cancer.

Recommended for you

What can salad dressing tell us about cancer? Think oil and vinegar

September 20, 2018
Researchers led by St. Jude Children's Research Hospital scientists have identified another way the process that causes oil to form droplets in water may contribute to solid tumors, such as prostate and breast cancer. The ...

Novel biomarker found in ovarian cancer patients can predict response to therapy

September 20, 2018
Despite months of aggressive treatment involving surgery and chemotherapy, about 85 percent of women with high-grade wide-spread ovarian cancer will have a recurrence of their disease. This leads to further treatment, but ...

Cancer immunotherapy might benefit from previously overlooked immune players

September 20, 2018
Cancer immunotherapy—efforts to boost a patient's own immune system, allowing it to better fight cancer cells on its own—has shown great promise for some previously intractable cancers. Yet immunotherapy doesn't work ...

Testing fluorescent tracers used to help surgeons determine edges of breast cancer tumors

September 20, 2018
A team of researchers with members from institutions in The Netherlands and China has conducted a test of fluorescent tracers meant to aid surgeons performing tumor removal in breast cancer patients. In their paper published ...

New way to target advanced breast cancers

September 20, 2018
A cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.

Understanding epilepsy in pediatric tumors

September 20, 2018
Pediatric brain tumors are characterized by frequent complications due to intractable epilepsy compared to adult brain tumors. However, the genetic cause of refractory epilepsy in pediatric brain cancer has not been elucidated ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.